arrow
Q

Quan Wang

nankai university
H指数:39
被引数:6,167

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stereotactic body radiotherapy plus lenvatinib and sintilimab with and without transarterial embolization for advanced hepatocellular carcinoma with portal vein tumor thrombus: a dual-center; propensity score-matched retrospective analysis

立体定向体部放射治疗联合乐伐替尼和信迪利单抗,联合或不含经动脉栓塞术治疗伴有门静脉癌栓的晚期肝细胞癌:一项双中心、倾向性评分匹配的回顾性分析

2026-03-040
OAAI
Efficacy and safety of levornidazole disodium phosphate injection in patients with intra-abdominal infections caused by anaerobic bacteria: a multicenter, randomized, single-blind, phase IV, non-inferiority trial (ANAEROGUARD study)

左ORNIDAZOLE二磷酸钠注射液在厌氧菌引起的腹腔感染患者中的疗效与安全性:一项多中心、随机、单盲、IV期、非劣效性试验(ANAEROGUARD研究)

2026-02-280
OAAI
Large-scale evaluation of HIV-1 DNA drug resistance testing as a robust tool for clinical decision-making: A nationwide study in China

HIV-1 DNA药物耐药性检测作为临床决策的可靠工具的大规模评估:一项在中国开展的国家性研究

2025-12-090
OAAI
Effects of stoma discharge reinfusion on low anterior resection syndrome and the gut microbiota following sphincter-preserving surgery for middle and low rectal cancer: a randomized clinical trial

经造口排泄物回输对中低位直肠癌保肛术后低前切除综合征及肠道菌群的影响:一项随机临床试验

2025-11-010
PRE
Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study

IBI310联合信迪利单抗新辅助治疗局部晚期MSI-H/dMMR结直肠癌:一项随机phase 1b研究

2025-10-020
OAAI
Total neoadjuvant chemoradiotherapy plus anti PD-1 for mid-to-low locally advanced rectal cancer: study protocol of a prospective; single arm; phase II study (STARS - RC06)

总新辅助化放疗联合抗PD-1治疗中低位局部晚期直肠癌:一项前瞻性、单臂、II期研究的研究方案(STARS - RC06)

2025-08-090
OA